Author:
Yu Jing,Du Yongjun,Liu Chang,Xie Yu,Yuan Mengci,Shan Meihua,Li Ning,Liu Chang,Wang Yue,Qin Junfang
Funder
National Natural Science Foundation of China
Reference56 articles.
1. Antibiotic resistance and persistence-implications for human health and treatment perspectives;Huemer;EMBO Rep.,2020
2. Targeted drug therapy to overcome chemoresistance in triple-negative breast cancer;Kumari;Curr. Cancer Drug Targets,2020
3. Breast cancer statistics;Giaquinto;CA Cancer J. Clin.,2022
4. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials;Lancet Oncol.,2022
5. G. Early Breast Cancer Trialists' Collaborative, C. Davies, J. Godwin, R. Gray, M. Clarke, D. Cutter, S. Darby, P. McGale, H.C. Pan, C. Taylor, Y.C. Wang, M. Dowsett, J. Ingle, R. Peto, Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials, Lancet 378 (2011) 771–784.